Achieving personalized healthcare for all people, including the most vulnerable Hispanic communities, may appear to be an insurmountable task or an impossible reality. Biotech pioneer and thought leader Genentech, a member of the Roche Group, has taken deliberate and strategic steps toward reaching this goal. Strategic priorities for this effort include developing policies focused on inclusive practices, increasing the amount of genomic data and scientific insights from underrepresented populations, and leveraging partner relationships to develop actionable strategies to increase clinical research participation. Through collaboration with the broader healthcare ecosystem, progress can be made to help remove systemic barriers for communities of color and build a future of precision medicine.
Copyright 2023, The Author(s).